Trends in insulin resistance: insights into mechanisms and therapeutic strategy

Тенденции развития инсулинорезистентности: механизмы и терапевтические стратегии
Sarra Setrerrahmane, Hanmei Xu, Mengwei Li, Ying Wang, Xiaowei Chi, Wenwei Xie, Xiaowei Chi
2022-07-06

adipokinesinsulin resistanceinsulin sensitivitymetabolic dysfunction-associated fatty liver diseasemetabolic syndrome
The centenary of insulin discovery represents an important opportunity to transform diabetes from a fatal diagnosis into a medically manageable chronic condition. Insulin is a key peptide hormone and mediates the systemic glucose metabolism in different tissues. Insulin resistance (IR) is a disordered biological response for insulin stimulation through the disruption of different molecular pathways in target tissues. Acquired conditions and genetic factors have been implicated in IR. Recent genetic and biochemical studies suggest that the dysregulated metabolic mediators released by adipose tissue including adipokines, cytokines, chemokines, excess lipids and toxic lipid metabolites promote IR in other tissues. IR is associated with several groups of abnormal syndromes that include obesity, diabetes, metabolic dysfunction-associated fatty liver disease (MAFLD), cardiovascular disease, polycystic ovary syndrome (PCOS), and other abnormalities. Although no medication is specifically approved to treat IR, we summarized the lifestyle changes and pharmacological medications that have been used as efficient intervention to improve insulin sensitivity. Ultimately, the systematic discussion of complex mechanism will help to identify potential new targets and treat the closely associated metabolic syndrome of IR.
1
Although no medication is specifically approved for insulin resistance, lifestyle modification and pharmacological treatments can improve insulin sensitivity; mechanistic understanding may reveal new therapeutic targets.
2
Both acquired conditions and genetic factors contribute to the development of insulin resistance.
3
Dysregulated adipose-derived mediators—including adipokines, cytokines, chemokines, excess lipids, and toxic lipid metabolites—can promote insulin resistance in other tissues.
4
Insulin resistance is associated with obesity, diabetes, metabolic dysfunction-associated fatty liver disease, cardiovascular disease, and polycystic ovary syndrome.
5
Insulin resistance reflects impaired biological responses to insulin caused by disruption of molecular signaling pathways in target tissues.

insulin resistance in systemic glucose-metabolism tissues and associated metabolic syndromes

molecular and metabolic mechanisms underlying insulin resistance and lifestyle and pharmacological strategies to improve insulin sensitivity

Publication Details
Publication Date
2022-07-06
Journal
Publisher
ISSN
Cited by
1087
Access Type
Author Information
Authors
Sarra Setrerrahmane
Hanmei Xu
Mengwei Li
Ying Wang
Xiaowei Chi
Wenwei Xie
Xiaowei Chi
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%